Clarity's Diagnosis and Treatment Guidance

Covering over 370 clinical topics for use in 

primary care, Clarity’s Diagnosis and Treatment Guidance supports confident decision-making at the point of care. 


Referenced and linked to source evidence and covering over 1,200 clinical presentations or patient scenarios, this guidance helps healthcare professionals:

  • Reach a diagnosis
  • Prescribe safely
  • Offer safe and effective treatment options or referral for specialist care
  • Create local protocols and guidance 

Practical clinical guidance for common conditions and symptoms

Clarity’s Diagnosis and Treatment Guidance will be available on subscription through MedicinesComplete, from January 2021*.


For more information or to sample selected content

*Clarity’s Diagnosis and Treatment Guidance is available only to customers outside of the UK

Clinical topics commissioned by National Institute for Health and Care Excellence (NICE) for use in the NHS

Evidence-based and rigorous content development process

Easily accessible at 

the point of care

Continually reviewed and updated, with new topics introduced regularly

A practical online resource to assess symptoms, diagnose

the disease and identify treatment options, including concise 

prescribing information

Sign up below to find out more, or to sample selected content:

This new resource will be available on subscription through MedicinesComplete to customers outside the UK from January 2021.


To be notified in advance of publication sign up here.

Clarity's Diagnosis and Treatment Guidance

Publication 2021

Clarity’s Diagnosis and Treatment Guidance (Clarity's DTG) is a Clarity Informatics product and forms the clinical content of the National Institute for Healthcare Excellence’s (NICE) Clinical Knowledge Summaries (CKS).

© The Royal Pharmaceutical Society 2020. All Rights Reserved.  

RPS is a company incorporated in England Under Royal Charter. Company Number RC000799. 66-68 East Smithfield, London, E1W 1AW, UK